Skip to main content
OpenTrials
Completed

NCT Number: NCT01130714

Resistance Training in Lung Cancer Patients on Chemotherapy

The purpose of this study is to examine the effectiveness of a resistance training program on reducing systemic inflammation and improving chemotherapy completion in lung cancer patients being treated with curative intent chemotherapy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Inflammation Lung Cancer Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Pathologic Processes Pathological Conditions, Signs and Symptoms Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Leo Jenkins Cancer Center

Greenville, North Carolina, 27834, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Histologically diagnosed with lung cancer
  • Stage I, II, or III
  • Eligible for chemotherapy with curative intent
  • 21 years of age or older
  • Approval to participate in study by treating oncologist or family physician

Exclusion criteria

  • Unstable cardiac disease
  • Untreated bone or brain metastases

Treatment and study plan

Exercise

Behavioral

Resistance training with resistance bands.

Primary outcomes

  1. Systemic inflammation measured by c-reactive protein.

    Time frame: 12 weeks

Secondary outcomes

  1. Chemotherapy completion

    Time frame: 12 weeks

Sponsors and collaborators

Lead sponsor

East Carolina University

Other

Registry information

Official study title

Effectiveness of a Resistance Training Program on Inflammatory Markers and Chemotherapy Completion in Lung Cancer Patients on Chemotherapy

Important dates

Study start
2010
Primary completion
2012
Study completion
2012
First posted
May 26, 2010
Registry last updated
Aug 20, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.